Radiopharmaceuticals - Global Market Trajectory & Analytics

Global Radiopharmaceuticals Market to Reach US$9.9 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Radiopharmaceuticals estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$9.9 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027.SPECT Radioisotopes, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$4.4 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PET Radioisotopes segment is readjusted to a revised 9.5% CAGR for the next 7-year period. This segment currently accounts for a 24% share of the global Radiopharmaceuticals market.

The U.S. Accounts for Over 47.7% of Global Market Size in 2020, While China is Forecast to Grow at a 12.7% CAGR for the Period of 2020-2027

The Radiopharmaceuticals market in the U.S. is estimated at US$2.5 Billion in the year 2020. The country currently accounts for a 47.74% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$645.7 Million in the year 2027 trailing a CAGR of 12.7% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR while Rest of European market (as defined in the study) will reach US$645.7 Million by the year 2027.

Beta Emitters Segment Corners a 16.5% Share in 2020

In the global Beta Emitters segment, USA, Canada, Japan, China and Europe will drive the 10.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$773.7 Million in the year 2020 will reach a projected size of US$1.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$481.1 Million by the year 2027, while Latin America will expand at a 11.3% CAGR through the analysis period.

Select Competitors (Total 78 Featured) -

• Actinium Pharmaceuticals, Inc.
• Alliance Medical
• Alseres Pharmaceuticals, Inc.
• Avid Radiopharmaceuticals
• Avid Bioservices Inc
• Bayer HealthCare Pharmaceuticals
• Bracco Diagnostics, Inc.
• Cardinal Health, Inc.
• GE Healthcare
• Ion Beam Applications S.A
• Immunomedics, Inc.
• Jubilant Pharma
• Lantheus Medical Imaging Inc.
• Medi-Radiopharma Ltd
• Nordion, Inc.
• Novartis/Advanced Accelerator Applications
• PETNET Solutions Inc.
• Positron Corporation